Monatepil maleate, identified by its CAS number 103379-03-9, is a chemical compound that serves primarily as a pharmaceutical agent. It is a salt formed from the combination of the active pharmaceutical ingredient Monatepil and maleic acid. This compound is characterized by its ability to act as a selective serotonin reuptake inhibitor (SSRI), which is utilized in the treatment of various mood disorders. The maleate form enhances the solubility and stability of the active ingredient, facilitating its absorption in biological systems. In terms of physical properties, it typically appears as a white to off-white crystalline powder. The compound is soluble in water and exhibits a moderate melting point, which is conducive to its formulation in various dosage forms. As with many pharmaceuticals, its safety profile, including potential side effects and contraindications, is crucial for clinical use, and it is subject to rigorous regulatory scrutiny. Overall, Monatepil maleate represents a significant advancement in therapeutic options for managing mental health conditions.

Monatepil maleate

103379-03-9: 1-Piperazinebutanamide, N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluorophenyl)-, (2Z)-2-butenedioate (1:1), 1-Piperazinebutanamide, N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluorophenyl)-, (±)-, (Z)-2-butenedioate (1:1), Dibenzo[b,e]thiepin, 1-piperazinebutanamide deriv., Monatepil maleate, AJ 2615

Monatepil maleate (AJ-2615 maleate) is a Ca2+-channel and α1-adrenergic receptor antagonist, and ACAT inhibitor with antihypertensive activity.

CAS 103379-03-9: Monatepil maleate

Monatepil maleate

Ref: TM-T25828